# |
PMID |
Sentence |
1 |
25629522
|
The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
|
2 |
25629522
|
Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
|
3 |
25629522
|
Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
|
4 |
25629522
|
ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
|
5 |
25629522
|
Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
|
6 |
25629522
|
Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
|
7 |
25629522
|
The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
|
8 |
25629522
|
Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
|
9 |
25629522
|
Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
|
10 |
25629522
|
ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
|
11 |
25629522
|
Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
|
12 |
25629522
|
Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
|
13 |
25629522
|
The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
|
14 |
25629522
|
Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
|
15 |
25629522
|
Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
|
16 |
25629522
|
ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
|
17 |
25629522
|
Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
|
18 |
25629522
|
Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
|
19 |
25629522
|
The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
|
20 |
25629522
|
Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
|
21 |
25629522
|
Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
|
22 |
25629522
|
ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
|
23 |
25629522
|
Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
|
24 |
25629522
|
Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
|
25 |
25629522
|
The capability of ASPH protein-derived HLA class I and II peptides to generate antigen specific CD4(+) and CD8(+) immune responses is unknown.
|
26 |
25629522
|
Helper CD4(+) T cells and CD8(+) cytotoxic T lymphocytes (CTLs) were co-incubated with the DCs; T cell activation was evaluated by flow cytometric analysis.
|
27 |
25629522
|
Immunoinformatics tools were used to predict HLA class I- and class II-restricted ASPH sequences, and the corresponding peptides were synthesized.
|
28 |
25629522
|
ASPH protein-loaded DCs activated both CD4(+) and CD8(+) T cells contained within the PBMC population derived from HCC patients.
|
29 |
25629522
|
Furthermore, the predicted HLA class I- and class II-restricted ASPH peptides were significantly immunogenic.
|
30 |
25629522
|
Both HLA class I- and class II-restricted peptides derived from ASPH induce T cell activation in HCC.
|